Long-term Outcomes of Single and Dual En Bloc Kidney Transplants From Small Pediatric Donors: An ANZDATA Registry Study
- PMID: 37492077
- PMCID: PMC10365191
- DOI: 10.1097/TXD.0000000000001518
Long-term Outcomes of Single and Dual En Bloc Kidney Transplants From Small Pediatric Donors: An ANZDATA Registry Study
Abstract
Kidney transplants from small pediatric donors are considered marginal and often transplanted as dual grafts. This study aimed to compare long-term outcomes between recipients of single kidney transplants (SKTs) and dual en bloc kidney transplants (EBKTs) from small pediatric donors.
Methods: Data were obtained from the Australia and New Zealand Dialysis and Transplant Registry. All adult recipients of kidney transplants from donors aged ≤5 y were identified. The primary outcome of interest was death-censored graft survival by donor type. The secondary outcomes were early graft loss, delayed graft function, serum creatinine posttransplantation, acute rejection, and patient survival.
Results: There were 183 adult recipients of kidney transplants from donors aged ≤5 y old. Of these, 60 patients had EBKT grafts, 79 patients had SKT grafts, and 44 patients had grafts of unknown type. Compared with SKT donors, EBKT donors had lower mean age (P < 0.001) and body weight (P < 0.001). There was no significant difference in death-censored graft survival between the groups, with median survival of 23.8 y (interquartile range 21.2-25) in the EBKT cohort and 21.8 y (11.6-26.8) in the SKT cohort (hazard ratio 1.3; 95% confidence interval, 0.59-2.64; P = 0.56). EBKT grafts had lower acute rejection rates than SKT grafts (P = 0.014). There was no significant difference observed between groups with respect to early graft loss, delayed graft function, posttransplantation serum creatinine posttransplantation, or patient survival.
Conclusions: EBKT and SKTs from small pediatric donors are associated with excellent long-term graft survival rates.
Copyright © 2023 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
D.W.J. has received consultancy fees, research grants, speaker’s honoraria, and travel sponsorships from Baxter Healthcare and Fresenius Medical Care, consultancy fees from Astra Zeneca, Bayer, BI and Lilly, Vifor, and AWAK, speaker’s honoraria and travel sponsorships from ONO Pharmaceutical Co. Ltd., and travel sponsorships from Amgen. He is a current recipient of an Australian National Health and Medical Research Council (NHMRC) Leadership Investigator Grant. A.K.V. is a current recipient of an NHMRC Emerging Leadership Investigator Grant and a Queensland Advancing Clinical Research Fellowship. The other authors declare no conflicts of interest.
Figures





References
-
- ANZDATA Registry. 41st Report, Chapter 6: Australian Transplant Waiting List. Australia and New Zealand Dialysis and Transplant Registry; 2019.
-
- Gourlay W, Stothers L, McLoughlin MG, et al. . Transplantation of pediatric cadaver kidneys into adult recipients. J Urol. 1995;153:322–5 6. - PubMed
-
- Bresnahan BA, McBride MA, Cherikh WS, et al. . Risk factors for renal allograft survival from pediatric cadaver donors: an analysis of United Network for Organ Sharing data. Transplantation. 2001;72:256–261. - PubMed
-
- Churchill BM, Sheldon CA, McLorie GA, et al. . Factors influencing patient and graft survival in 300 cadaveric pediatric renal transplants. J Urol. 1988;140(5, Part 2):1129–1133. - PubMed
-
- Balamuthusamy S, Paramesh A, Zhang R, et al. . The effects of body mass index on graft survival in adult recipients transplanted with single pediatric kidneys. Am J Nephrol. 2009;29:94–101. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials